Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital for Agitated Delirium
NCT07548489Phase 3Not yet recruiting
- Sponsor
- Duke University
- Start
- Jun 2026
- Primary completion
- Jan 2027
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of phenobarbital in delirium, sponsored by Duke University. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
phenobarbital
03
Conditions
delirium
Beyond the preview
Go deeper on NCT07548489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07548489.